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sprouty Encodes a Novel Antagonist of FGF
Signaling that Patterns Apical Branching
of the Drosophila Airways
an epithelial sac that gives rise to one tracheal hemiseg-
ment by sequential branching events (Samakovlis et al.,
1996). Six primary branches bud from specific positions
in the sac (Figure 1A). These branches are formed by
groups of 3±20 cells that migrate out in different direc-
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branches then elongate and form unicellular secondaryPrinceton University
branches (Figure 1B). Most secondary branch cells goPrinceton, New Jersey 08544
on to extend long cytoplasmic processes that form
arrays of fine terminal branches that cover the larval
tissues (Figure 1C). Different sets of genes are ex-Summary
pressed in or near the cells that form each type of
branch, and studies of these genes have begun to eluci-Antagonists of several growth factor signaling path-
date the pathways that control the branching pattern.ways play important roles in developmental patterning
The branchless gene encodes a fibroblast growth fac-by limiting the range of the cognate inducer. Here, we
tor (FGF) homolog (Bnl) that plays a key role inpatterningdescribe an antagonist of FGF signaling that patterns
the early branching events (Sutherland et al., 1996). Bnlapical branching of the Drosophila airways. In wild-
is required for branching and is expressed dynamicallytype embryos, the Branchless FGF induces secondary
in discrete clusters of cells surrounding the developingbranching by activating the Breathless FGF receptor
tracheal sacs at each position where a new branch willnear the tips of growing primary branches. In sprouty
bud. The secreted growth factor activates the breathlessmutants, the FGF pathway is overactive and ectopic
FGF receptor (Btl), a receptor tyrosine kinase (RTK) ex-branches are induced on the stalks of primary branches.
pressed on all tracheal cells (Glazer and Shilo, 1991;We show that FGF signaling induces sprouty expres-
Lee et al., 1996), and guides tracheal cell migrationssion in the nearby tip cells, and sprouty acts nonauton-
during primary branch formation. Bnl also has a secondomously and in a competitive fashion to block signal-
role in branch patterning: it induces the later programs ofing to the more distant stalk cells. sprouty encodes a
branching in cells near the ends of the growing primarynovel cysteine-rich protein that defines a new family
branches and in this way contributes to the apical biasof putative signaling molecules that may similarly
in secondary branching. This function appears to befunction as FGF antagonists in vertebrate devel-
transduced by a typical RTK signaling cascade (Suther-opment.
land et al., 1996; Hacohen, 1997) that culminates in the
MAPK-dependent degradation of Yan, an ETS domain
transcription factor (Lai and Rubin, 1992), and the induc-Introduction
tion of the downstream effector genes pointed (pnt),
another ETS domain transcription factor (Klambt, 1993),A major goal of developmental biology is to understand
and blistered (pruned), which encodes DSRF, the Dro-the molecular basis of organogenesis: how organs ac-
sophila homolog of mammalian serum response factorquire their complex three dimensional structures. This
(Affolter et al., 1994; Guillemin et al., 1996).is an especially challenging goal for organs like the lung,
In this paper, we describe another key regulator ofthe vascular system, and the insect tracheal system,
branching called sprouty (spry). Unlike mutations inwhich are composed of vast branching networks of epi-
other tracheal genes, which result in abnormal or miss-thelial tubes. How is budding of new branches regulated
ing branches, spry mutations cause excessive branch-during development togive rise to the complex arboriza-
ing. The extra branches sprout from thestalks of primarytion patterns? One patterning principle operative in
branches, close to the tips where secondary branchessome organs is that new branches tend to sprout from
normally bud. We show that this relaxation in the normalthe apical or growing ends of branches, as in many
apical restriction to branching results from overactivityplants. Here, we describe the molecular basis for an
of the Bnl pathway. Molecular analysis shows that spryapical bias in tracheal branching and show that it results
encodes a novel inhibitor that limits the range of Bnlfrom the interplay between an FGF inducer of branching
signaling and thus restricts secondary budding to apicalcalled Branchless and a novel antagonist we designate
positions closest to the FGF signaling centers. The SprySprouty.
protein defines a new family of putative signaling mole-The Drosophila tracheal system is a ramified network
cules that might similarly function as antagonists of FGFof epithelial tubes that delivers oxygen throughout the
pathways in vertebrate development.body (Manning and Krasnow, 1993). It arises at midem-
bryogenesis from 20 clusters of ectodermal cells. Each
Resultscluster of approximately 80 cells invaginates and forms
spry Mutations Cause Ectopic Branching³To whom correspondence should be addressed.
spry mutations were generated by imprecise excision§Present address: National Institute of Genetics, 1111 Yata, Mi-
shima, Shizuoka 411-8540, Japan. of a P[lacZ] transposon at band 63D1,2 that expresses
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Table 1. Number of Branches Emanating from the Dorsal
and Ganglionic Branches in spry Mutants
Genotype Dorsal Branch* Ganglionic Branch*
Canton-S (wild type) 1.0 6 0.3 (n 5 268) 1.0 6 0.2 (n 5 380)
spryD5/spryD5 2.2 6 0.6 (n 5 68) 1.7 6 0.6 (n 5 178)
spryD5/Df(3L)1226 2.2 6 0.6 (n 5 39) 1.6 6 0.5 (n 5 110)
spryD64/spryD64 1.7 6 0.6 (n 5 90) 1.4 6 0.5 (n 5 115)
spryD55/spryD55 1.7 6 0.5 (n 5 69) 1.4 6 0.5 (n 5 109)
spry211/spry211 2.3 6 0.4 (n 5 16) 1.3 6 0.5 (n 5 27)
spry226/spry226 2.0 6 0.5 (n 5 16) 1.6 6 0.5 (n 5 50)
spry254/spry254 1.8 6 0.6 (n 5 32) 1.7 6 0.7 (n 5 18)
spryF7/spryF7 1.8 6 0.4 (n 5 18) 1.4 6 0.5 (n 5 40)
spryG5/spryG5 2.0 6 0.6 (n 5 32) 1.2 6 0.4 (n 5 40)
* Fine branches were counted in mutant embryos stained with
mAb2A12 to visualize the tracheal lumen, mAb2-161 to mark
branching cells, and anti-b-gal to distinguish homozygotes from
heterozygotes carrying the 35UZ-2 TM3 lacZ balancer chromo-
some. The dorsal branch also gives rise to a fusion branch that was
unaffected and not included in the analysis. n, number of tracheal
hemisegments scored.
the b-galactosidase marker in tracheal cells as they are
forming new branches. The original P[lacZ] insert (Pan-
tip-2/s2683; Samakovlis et al., 1996) was a silent muta-
tion. Three P excision alleles, designated spryD5, spryD64,
and spryD55, showed excessive tracheal branching and
comprised a lethal complementation group. In spryD5
homozygotes, 30%±120% more branches than normal
budded from the DB, LTa, LTp, GB, and VB primary
branches (Figures 1D±1K; Table 1). The extra branches
were not distributed randomly but rather arose from the
stalks of the primary branches, close to the positions
where secondary and terminal branches normally bud
(e.g., compare Figures 1G and 1E).
and [C]; e.g., DB1) ramify to form fine terminal (38) branches (C).
Others (e.g., DB2) remain as unicellular tubes that fuse to branches
in neighboring hemisegments (dotted lines) to link up the tracheal
network. DTa, dorsal trunk anterior; DTp, dorsal trunk posterior; VB,
visceral branch; LTa, lateral trunk anterior; GB, ganglionic branch.
Dorsal is up, and anterior is left in all figures unless otherwise noted.
Bars, 10 mm.
(D±K) Stage-16 wild-type (1) and spryD5 mutants stained with
mAb2A12 to show tracheal lumen. (D) Dorsal midline view of wild-
type DBs. The Tr5 DBs are circled. (E) Close-up of a wild-type DB.
One fine branch is extending (arrowhead). (F) Dorsal midline view
of a spryD5 mutant. Note extra branches. (G) Close up of a spryD5
DB. Three fine branches are extending (arrowheads). (H) Ventral
midline view of wild-type GBs. (I) Close-up of a wild-type GB. A
single fine branch is extending (arrowhead). (J) Ventral midline view
of a spryD5 mutant. Note extra branches. (K) Close-up of a spryD5
GB. Two fine branches are extending (arrowheads). Dashed lines
in (E), (I), and (K), continuations of branches outside focal plane.
Bars in (J) (for [D], [F], [H], [J]) and K (for [E], [G], [I], [K]), 10 mm.
(M±P) Stage-16 embryos double stained for mAb2A12 antigen and
the btl-lacZ marker 6-81a to show tracheal cell nuclei (numbered)
and fine (secondary/terminal) branches (arrowheads). (M) Wild-type
Figure 1. Ectopic Branching in spry Mutants DB. (N) spryD5 DB. Note the extra branch-forming cell, DB3. (O)
(A±C) Normal branching in tracheal hemisegment Tr5 at embryonic Tracing of wild-type GB. (P) Tracing of spryD5 GB. Note the extra
stages 12 (z8 hr) and 16 (z14 hr) and in the Tr5 dorsal branch (DB) branch-forming cell, GB2. Bar in (M) (for [M±P]), 5 mm.
in the third larval instar (z100 hr). Lumens of the epithelial tubes (Q) Dorsal midline view of pair of DBs in wild-type third instar larva
are outlined and typical positions of cell nuclei are shown by filled showing arborization of the normal secondary branches (arrow-
circles. Six primary branches form first (A). Then individual cells like heads). (R) Same view of spryD5 larva showing arborization of the
DB1 and 2 at the ends of growing primary branches form secondary normal and extra secondary branches (arrowheads). Bar in (Q),
branches (B). Most secondary branch cells (nuclei filled black in [B] 10 mm.
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Five EMS-induced spry alleles were recovered in an 1996; Figures 2A and 2D). Similarly, the DSRF gene and
three other marker genes (Terminal -2,-3, and -4) areunrelated screen for suppressors of a dominant eye
phenotype (see Experimental Procedures). All eight spry induced at the ends of growing primary branches and
promote terminal branching (Figures 2F and 2H). In sprymutations had a similar tracheal phenotype (Table 1)
and were pupal lethal in trans to deficiencies in the 63D mutants, all five downstream effectors were expressed
in expanded domains that included the prestalk cellsregion, including Df(3L)1226, Df(3L)1227, Df(3L)Hr119,
and Df(3L)Hr232. spryD5 homozygotes displayed as se- that later formed ectopic branches (Figures 2B, 2E, 2G,
and 2I; data not shown). Furthermore, the DSRF markervere a tracheal phenotype as spryD5 hemizygotes (spryD5/
Df(3L)1226 and spryD5/Df (3L)Hr298), implying that spryD5 was activated at the same time as in the normal
branching cells (Figures 2J and 2K).is a genetic null allele (Table 1 and data not shown).
Another critical target of Bnl signaling is the transcrip-
tional repressor Yan. As in other RTK pathways (O'NeillTracheal Stalk Cells Adopt a Branching
et al., 1994; Rebay and Rubin, 1995; Gabay et al., 1996),Fate in spry Mutants
activation of the Btl receptor leads to MAPK-depen-The cellular basis of the extra branching phenotype was
dent phosphorylation and degradation of Yan, whichinvestigated by staining spry mutants with tracheal cell
is necessary to activate the later programs of trachealand nuclear markers. There were extra branch-forming
branching (N. H. and D. S., unpublished data). Normally,cells in the mutants, each forming a single branch at
Yan is degraded only in the tip cells of the outgrowingstage 16 just like normal secondary branch cells (Figures
primary branches (Hacohen, 1997). In spry mutants, Yan1M±1P). The extra branching cells did not arise from
was degraded in an expanded domain that coincidedextra cell divisions. Cell counts showed that the total
with the expanded domains of pnt and DSRF expressionnumber of tracheal cells was not increased in the spryD5
(Figure 2L and 2M). A yan-lacZ transcriptional reportermutant (78 6 4 cells in the Tr5 tracheal hemisegment in
continued to be expressed normally, implying thatwild type [n 5 6] vs. 73 6 3 cells in spryD5 [n 5 3]), even
down-regulation of Yan occurs posttranscriptionally asthough the number of cells forming fine branches was
in other RTK pathways (Figure 2N).substantially increased (from z20 to z30 in Tr5). Fur-
The results show that spry loss of function mutationsthermore, no additional dividing cells were detected in
enhance all known downstream effects in this Bnl path-spryD5 embryos labeledwith BrdU or a string-lacZ marker
way. We also found that an engineered gain of functionthat expresses lacZ in dividing tracheal cells. It is also
condition, in which the spry gene product was over-unlikely that the extra branching cells arose by suppres-
expressed during embryonic stages 10±12, severelysion of cell death, because cell death does not occur
blocked induction of downstream effectors and branch-in normal tracheal development (Samakovlis et al.,
ing by Bnl (Figures 2O and 2P). The reciprocal is also1996), and we found no extra branches in H99 mutant
true: overexpressionof Bnl can overcome theoppositionembryos, which lack all normal apoptosis (White et al.,
of spry and induce secondary and terminal branching1994). Rather, the extra branching cells appear to arise
throughout the tracheal system (Sutherland et al., 1996).by a change in tracheal cell fate, with normally non-
Thus, spry behaves genetically as a competitive inhibitorbranching stalk cells recruited to thebranching fate. This
of the Bnl pathway.interpretation is supported by the finding that secondary
and terminal branch markers were inappropriately acti-
vated in prestalk cells at the same time in development spry Acts Nonautonomously in Tip Cells to Inhibit
as in normalbranching cells (see below). These cells also Induction of Nearby Stalk Cells
followed the same developmental program as normal To determine in which cells spry1 function is required,
secondary branch cells, forming extensive arrays of ter- we carried out a genetic mosaic analysis using the FLP
minal branches in the larva (Figures 1Q and 1R). recombination system (Xu and Rubin, 1993). We exam-
ined 33 mosaic GBs composed of spry2 and spry1 cells.
In the 29 clones in which just the tracheal tip cell GB1spry Antagonizes the Bnl Pathway
Secondary and terminal branching genes are induced was spry2, an ectopic branch was always present in the
neighboring spry1 stalk cell, GB2 (Figure 3A). In contrast,at the ends of growing primary branches by localized
expression of the Bnl FGF in surrounding tissues (Suth- in three of the four clones of the opposite type in which
a subset of the other stalk cells (GB2-7) were spry2, theerland et al., 1996). Because the ectopic branches in
spry mutants are formed by the prestalk cells located GB appeared normal with no extra branches (Figure 3B).
We presume that the single exceptional clone repre-near the cells that are normally induced to branch, the
extra branches could arise from overactivity of the Bnl sents the rare situation in which a second GB cell can
take on the branching fate even in the presence of wild-pathway. To test whether spry1 functions by limiting the
Bnl pathway or prevents branching in some other way, type spry function. One particularly informative spry2
clone included all of the GB cells except the tip cell;we examined the effect of spry mutations on down-
stream effectors in the Bnl pathway that regulate the this formed a normal GB without ectopic branches. We
conclude that spry1 is required in the tip cell and actslater branching events.
One effector tested was pnt, a downstream target of nonautonomously to inhibit branching by nearby stalk
cells. Data for the DB were more limited, but they sup-several RTK pathways (O'Neill et al., 1994; Gabay et al.,
1996). pnt expression is induced by Bnl at the ends of ported the results for the GB. In all four clones in which
the tip cell DB1 was spry2, nearby spry1 cells formedprimary branches and promotes secondary and terminal
branching (Samakovlis et al., 1996; Sutherland et al., ectopic branches (Figure 3C).
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Figure 2. Effect of spry Mutations on the Bnl
Pathway
(A±E) Effect of spry mutations on expression
of the Bnl-induced genes pnt and spry. The
pnt7825 and spryD55 enhancer trap markers
were used as reporters and mAb2A12 to label
tracheal lumen. (A) Wild-type DB, stage 16.
High-level expression of pnt is seen only in
DB1. (B) spryD5 homozygote. pnt is ectopically
expressed in DB3. (C) spryD55/spryD64 loss of
function mutant. The spry reporter is ectopi-
cally expressed in DB3 in addition to the nor-
mal expression in DB1 (see Figure 5K). (D)
Wild-type GB, stage 16. High-level expres-
sion of pnt is seen only in GB1. (E) spryD5
homozygote. pnt is ectopically expressed in
GB2.
(F±K) Effect of spry mutations on expression
of DSRF, the product of a Bnl-induced gene
that controls terminal branching. (F) Wild-
type DB, stage 16. DSRF expression (mAb2-
161) is seen only in DB1. (G) spryD5 homozy-
gote. DSRF is ectopically expressed in DB3.
(H) Wild-type GB, stage 16. DSRF is seen only
in GB1. (I) spryD5 homozygote. DSRF is ectopi-
cally expressed in GB2. (J) Wild-type GB,
stage 13. DSRF is just beginning to be ex-
pressed in DB1. mAb2A12 antigen is not yet
on. (K) GB in spryD5 homozygote, stage 13.
DSRF turns on in GB2 at the same time as
GB1. Similar results were obtained for three
other terminal branch markers (Terminal -2,
-3, and -4).
(L±N) Effect of spry mutations on Yan expres-
sion. In wild type, Bnl signaling leads to deg-
radation of Yan in DB1 and DB2 (Hacohen,
1997). (L) In the spryD5 mutant, Yan (mAb A2
8B12; pseudocolored green) is also degraded
in DB3 (asterisk). Embryo was also stained
for DSRF (mAb2-161; pseudocolored red) to
show positions of DB1 and DB3. (M) Same
as (L) without DSRF channel. (N) Expression
of the yan-lacZ enhancer trap marker yanP is not changed in a spryD5 mutant. Bars in (L) and (N), 5 mm.
(O and P) Effect of elevated levels of spry. (O) Three DBs of wild-type stage-14 embryo, showing expression of DSRF in the DB1 cells
(arrowheads). (P) Similar view of a stage-14 hsGal4/UAS-spry 4.1 embryo heat-shocked at late stage 10 to induce spry expression. DSRF fails
to be expressed (arrowheads), and terminal branching is inhibited. When expression of spry was induced later at stage 13 or 14, branching
was usually not inhibited and extra branching cells were sometimes observed (data not shown).
There were two unexpected characteristics of the expressed just after tracheal development begins. The
same probe identified 11 cDNA clones that corre-clones in which the GB1 cell was spry2. First, outgrowth
of ectopic branches from GB2 and GB3 usually turned sponded to three transcript classes of a single gene
(Figure 4A). We determined that these cDNAs representaway from the ventral nerve cord (VNC) (Figure 3A),
whereas in spry2 embryos the extra branches normally the spry gene. First, in situ hybridizations with the cDNAs
as probes detected an RNA expression pattern that cor-entered the VNC (Figures 1J and IK). This indicates that
the remaining spry1 cells in the mosaic individuals responded precisely to the lacZ expression pattern in
the three spry enhancer trap lines (see below). Second,somehow influence tracheal pathfinding. Second, we
noticed that growth of the normal branch from a spry2 all eight spry alleles have lesions in the identified tran-
scription unit. In spryD5 and spryD64, the 59 exon commonGB1 cell sometimes appeared to be slowed when
nearby cells (GB2-7) were spry1. This suggests that to all splice forms was deleted (Figure 4A), and in the
other excision allele (spryD55) there was a complex re-spry1 might also have a cell-autonomous function that
protects it from the inhibitory effects of its spry1 neigh- arrangement that included this exon (data not shown).
Sequence analysis revealed nonsense or frameshift mu-bors (see Discussion).
tations in all five EMS alleles that would produce trun-
cated polypeptides lacking all or most of the conservedspry Encodes a Putative Secreted Protein
with a Conserved Cysteine-Rich Motif protein motif (Figure 4C). Finally, Spry immunoreactivity
was absent in the spryD5 mutant (see below).Genomic DNA flanking a spry P[lacZ] insertion was
isolated by plasmid rescue and used to probe Northern Nucleotide sequencing of cDNAs identified a single
long open reading frame that predicts a 591-residue (63blots of embryonic RNA (Figures 4A and 4B). A set of
3.2±4.4 kb mRNAs was detected that began to be kD) polypeptide (Figure 4C). Its most striking feature is
Sprouty, an Antagonist of FGF Signaling
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Spry in embryos. However, when Spry was overex-
pressed in the developing tracheal system using the
GAL4/UAS system, Spry staining was found at the
plasma membrane and generally colocalized with that
of a control transmembrane protein (Figures 5A±5C).
This suggests that Spry is a membrane-associated pro-
tein or a secreted protein that remains close to the Spry-
expressing cells. Spry also localized to the plasma mem-
Figure 3. Phenotype of spry Mutant Clones brane of transfected human 293 cells, and although
Homozygous spryD5 clones were generated by FLP-mediated re- most of the protein remained tightly associated with the
combination in heterozygous embryos of the genotype hsFLP; cells, a few percent could be released into the medium
spryD5, FRT / 1-eve-1, FRT and stained for mAb2A12 antigen and
by addition of heparin at 10 mg/ml (data not shown).
b-gal. Homozygous spryD5 cells have lost the spry1 chromosome
carrying the 1-eve-1 tracheal lacZ marker and therefore show little or
no b-gal staining of tracheal nuclei or cytoplasm, although lumenal
spry Is Expressed at the Tips of GrowingmAb2A12 staining remains.
(A) A GB clone. The ends of three GBs entering the ventral nerve Primary Branches
cord (VNC) are shown. The tip cell (GB1*) of the middle GB shows The embryonic expression pattern of spry was deter-
thin lumenal staining but no staining of the surrounding cytoplasm mined by whole-mount in situ hybridization and by anal-
or nucleus and hence is homozygous for spryD5. Note the ectopic
ysis of three spry enhancer trap markers that closelybranch (arrowhead) arising from the neighboring GB2 cell. Scattered
followed mRNA expression (Figures 5D±5G) and pro-cells in the VNC (below dashed white line) also express the 1-eve-1
vided cellular resolution of the pattern. spry was ex-marker.
(B) Another GB clone. The GB2 cell (GB2*) of the leftGB lacks nuclear pressed specifically in the tracheal system and a few
b-gal expression (although weak cytoplasmic staining persists) and other developing tissues, including midline glia (Figures
is therefore homozygous for spryD5. No ectopic branches are seen. 5F and 5G), where bnl and btl also function (KlaÈ mbt et
(C) A DB clone. The DB1 cell (DB1*) shows thin lumenal staining
al., 1992), and the dorsal vessel, where the other knownbut no b-gal staining of the surrounding cytoplasm or nucleus and
Drosophila FGF pathway is operative (Beiman et al.,thus is homozygous for spryD5. The neighboring DB3 and DB4 have
1996). spry was also expressed in a small subset of VNCformed ectopic branches. Dashed black line, continuation of DB
outside focal plane. Bar, 10 mm. neurons (Figure 5G), oenocytes (see Figure 6C), and,
later, in the eye imaginal disc (S. K. et al., unpublished
data).
Tracheal expression was first detected in the primarya 124-residue cysteine-rich region (22 cysteines), which
branches as they begin to bud, and it was maintainedis flanked by N- and C-terminal cysteine-free regions
at high levels at the ends of branches in cells that gothat contain many stretches of repeated or alternating
on to form secondary and ultimately terminal branches,amino acids. There are eight potential N-linked glycosyl-
consistent with the genetic mosaic analysis. In the DB,ation sites. There is a predicted signal peptide near
spry was expressed at stages 12 and 13 in the DB tipthe N terminus but no clear transmembrane domains,
cells (DB1, 2) and less intensely in the trailing cells DB3suggesting that Spry protein may be secreted.
and DB4 (Figures 5H and 5I). The tip cells soon begin toAn NCBI BLAST search of the combined databases
separate from each other and form discrete secondarydid not detect any closely related proteins. However, a
branches. After stage 13, spry was expressed mostsearch of the expressed sequence tag (dbEST) database
strongly in DB1 and ultimately in this cell alone, the onlyidentified three human homologs designated h-Sprouty1,
one that continues to branch (Figures 5J and 5K).h-Sprouty2, and h-Sprouty3. We determined a com-
plete coding sequence of h-Spry2and a partial sequence
of h-Spry1 from overlapping cDNAs. The h-Spry2 se-
spry Expression Is Induced by the Bnl Pathwayquence encodes a 315-residue (35 kD) polypeptide (Fig-
The tracheal cells that express spry are located veryure 4D). It contains a cysteine-rich domain, which is
close to the small clusters of epidermal and mesodermalhighly conserved with Spry (51% identity, with 21 of the
cells that express Bnl (see Sutherland et al., 1996; sche-22 Spry cysteines conserved), and two additional short
matized in Figure 6A), and the spry expression patternstretches of similarity to Spry in the N-terminal region
is very similar to that of pnt and other genes inducedbut no predicted signal peptide. h-Spry1 and h-Spry3
by Bnl (Samakovlis et al., 1996). These observationsalso show strong conservation of the cysteine-rich do-
suggested that spry might also be induced by the Bnlmain, with 51%±70% identity to other family members
pathway. Consistent with this, in bnl and btl mutants,in the available sequences.
spry was not expressed or was expressed only weakly
(Figure 6C and data not shown). Furthermore, when Bnl
was ubiquitously expressed, spry turned on at high lev-Spry Protein Localizes to the Plasma Membrane
We prepared affinity-purified antisera to full-length Spry els throughout the tracheal system (Figure 6D). The
downstream effector pnt was also required for spry ex-protein and to N- and C-terminal fragments. These anti-
sera detect Spry in eye imaginal discs where spry also pression (Figure 6E), and spry expression was activated
outside its normal expression domain when pnt P1 pro-functions, and they are specific for Spry because the
staining is absent in spryD5 mutants (S. K. et al., unpub- tein was ubiquitously expressed (Figure 6F). Consistent
with this, pnt spry double mutants display the samelished data). Unfortunately, none of the antisera were
sensitive enough to reproducibly detect endogenous tracheal phenotype as the pnt mutant alone (data not
Cell
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Figure 4. Structure of the spry Locus, cDNA
Sequence, and Sequence of Human spry Ho-
mologs
(A) Restriction map of spry locus and struc-
tures of the three cDNA classes (I, II, III). Open
boxes, exons; filled portion, coding region.
Triangle shows P element s2683 insertion
site. Genomic DNA removed in two s2683 ex-
cision alleles is indicated above map. The ge-
nomic DNA in the BamHI rescue plasmid
pNH6001 and several l phage genomic clones
(FG3.5, G1.1, and G1.2) are also shown. R,
EcoRI; S, SalI; B, BamHI.
(B) Northern blot of 2 mg (lanes 1±3) and 4 mg
(lanes 4 and 5) of poly(A)1 RNA from wild-
type embryos of the indicated ages. Probe
was 8 kb spry genomic fragment from
pNH6001. The same result was obtained with
cDNA 12.2 as probe. RNA size standards are
indicated.
(C) Sequence of spry cDNA 12.2 and Spry
protein. The start of the class II cDNA 13.3 is
indicated by the thick arrowhead in this class
I cDNA sequence. Thin arrowhead is the end
of the first exon. Nucleotides preceding the
designated translation start site match the
Drosophila consensus [C/A]AA[A/C] at 3 of 4
positions. The putative signal peptide is
boxed and the proposed cleavage site is indi-
cated by an asterisk. The cysteine-rich do-
main and two short regions of homology with
the human homologs are highlighted in gray.
Repeated or alternating amino acids are
underlined, and potential N-glycosylation
sites are in bold. Positions of EMS-induced
nonsense mutations are circled: spry226:
C2055→T; spry211: C2253→T; spryG5: G2710→A;
spryF7: C2466→T. In the spry254 allele, nucleo-
tides 2237-2243 (gray oval) are replaced by
TA, causing a frameshift that adds 134 new
residues. The sequence of the unique exon
of the class III cDNA (data not shown) did
not contain any long open reading frames,
suggesting that it is an incomplete cDNA or
represents a nonfunctional transcript.
(D) Human Spry homologs. Full h-Spry2 se-
quence and partial sequences of h-Spry1 and
h-Spry3 are aligned with the Drosophila Spry
sequence. Dots represent gaps inserted to
maximize alignment. Numbers in parenthe-
ses indicate the number of Spry residues not
shown. The cysteine-rich domain and two
short regions of homology with Spry are
boxed. Asterisks show the cysteines in Spry,
and (*) is the one not conserved in h-Spry2.
shown). These results show that spry expression is in- primary branches by patches of Bnl expression located
just ahead of the growing branches. In spry mutants,duced by the signaling pathway that it inhibits. Spry
limits induction of its own gene, just as it limits induction the prestalk cells located at a somewhat greater dis-
tance from the Bnl signaling centers expressed all ofof other genes by Bnl, as shown by the broadened ex-
pression domain of a spry-lacZ marker in a spry2 back- the known Bnl effectors and were induced to bud like
the normal secondary branch cells. Thus, spry1 limitsground (Figure 2C).
induction of new branches by the Bnl pathway. Mosaic
analysis demonstrated that spry acts nonautonomouslyDiscussion
in the normal branching cells to prevent induction of
nearby stalk cells. Consistent with this, we found thatSpry Is a Novel Antagonist of the Bnl
FGF Pathway the spry gene was expressed in the normal branching
cells and encodes a novel membrane-associated or se-We have identified an inhibitor of tracheal branching
called Sprouty and shown that it restricts branch bud- creted protein. Thus, Spry is an inhibitory signal that
opposes the Bnl pathway.ding by antagonizing the Bnl FGF pathway. Normally,
secondary branches are induced at the tips of growing A fine balance between inducer and inhibitor is critical
Sprouty, an Antagonist of FGF Signaling
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Figure 5. spry Expression Pattern and Pro-
tein Localization
(A±C) Spry protein localizes to the plasma
membrane. Spry was expressed throughout
the tracheal system using the Gal4/UAS sys-
tem. The C38::Gal4; UAS-spry1.3 stage-14
embryo was stained with an affinity-purified
antiserum (26A) raised against full length Spry
(A) and with mAb C17.9C6 against the trans-
membrane protein Notch to mark the cell sur-
face (B). In the merged image (C), yellow rep-
resents overlap of Spry and Notch staining.
A portion of the DT and two DBs is shown
(dorsal left, anterior down). Bar, 5 mm.
(D±G) Embryonic expression pattern. spry
RNA expression was detected by in situ hy-
bridization (D and F) or b-gal and tracheal
lumenal immunostaining of the spry9143 en-
hancer trap marker (E and G). The expression
patterns are very similar, except spry RNA
is detected approximately 1 hr before b-gal
protein. (D) and (E) show expression in vis-
ceral branches (VB) at stage 14 and late 15,
respectively. (F) and (G) show expression in
midline glia (MG) at similar stages. The GB1
tracheal cell expression seen in G (arrow-
head) is also detectable by in situ hybridiza-
tion in embryos slightly older than the one in
(F).
(H±K) Expression of spry in developing tra-
cheal DB, visualized by b-gal and tracheal
immunostaining as above. The numbers of
the expressing DB cells are shown. Bar in (K)
(for H±K), 5 mm.
for proper patterning. Overexpression of Bnl overcomes expressed in bnl or btl mutants, and its expression was
turned on throughout the tracheal system by ubiquitousthe inhibitory effects of Spry, inducing secondary and
terminal branches everywhere in the tracheal system expression of Bnl. Thus, bnl and spry comprise a nega-
tive feedback circuit that is finely tuned to allow only(Sutherland et al., 1996). Conversely, we found that over-
expression of Spry during embryonic stages 10±12 pre- short range signaling by Bnl.
vented induction of secondary and terminal branches.
Even small alterations in the levels of these antagonistic How Does Spry Antagonize Bnl Signaling?
Given the competitive genetic interactions and that bothsignals can be significant, as sporadic ectopic branches
are observed in individuals carrying an extra copy of appear to be membrane-associated or secreted pro-
teins, the simplest biochemical model is that Spry com-the bnl gene (J. Jarecki and M. K., unpublished data).
Our molecular epistasis experiments show that the petes with Bnl for binding to the Btl receptor or that it
restricts receptor activation in some other way, such asantagonistic signals are integrated in an unusual regula-
tory circuit (Figure 6G). The most unusual feature of the by binding Bnland limiting its diffusion. It is also possible
that Spry has its own receptor. The short-range inhibi-circuit is that expression of the antagonist is activated
by the signaling pathway that it inhibits: spry was not tory action of Spry is reminiscent of lateral inhibitory
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cells that express highest levels of the inhibitor. Al-
though this is a consequence of the induction of spry
expression by the Bnl pathway (Figure 6G), it is unclear
how expression of spry and other effectors is maintained
once Spry protein is present. Perhaps high levels of Bnl
simply outcompete high levels of Spry. Alternatively,
there may be special mechanisms that allow Spry-
expressing cells to escape their own inhibitory effect,
as suggested by the possible cell autonomous function
of spry noted in the genetic mosaic analysis.
Spry Defines a New Family of Putative
Growth Factor Antagonists
Antagonists of several major signaling pathways have
been identified recently. Like Spry, each of these ap-
pears to play an important role in developmental pat-
terning by limiting the range of signaling by the cognate
inducer. Several, including Chordin/SOG (Piccolo et al.,
1996) and Noggin (Zimmerman et al. 1996), antagonize
signaling by TGF-b family members and thereby pro-
mote neural development or restrict dorsalization of the
ectoderm. Similarly, secreted Argos protein limits EGF
signaling during ventral embryonic patterning and eyeFigure 6. Regulation of spry Expression by the bnl Pathway
development in Drosophila (Schweitzer et al., 1995). The(A) A cluster of Bnl-expressing cells (blue circles) near the end of a
parallels between Spry and Argos are particularly strik-growing DB (Sutherland et al., 1996). Secreted Bnl (blue dots) causes
ing because both antagonize RTK signaling pathwaysbudding (stage 12) and outgrowth (stage 14) of the primary branch.
It also induces expression of genes like pnt and DSRF that promote and both function in analogous feedback circuits in
secondary and terminal branching in cells at the end of the primary which expression of the inhibitor is induced by the ligand
branch (green fill), which go on to form secondary (stage 16) and whose signaling it blocks (Golembo et al., 1996). Al-
terminal branches (larva). spry is expressed in the same pattern as
though none of the antagonists show substantial se-pnt (see Figures 5H±5K). DB cell numbers are shown at stage 16.
quence similarity to the cognate inducer, all are cyste-(B±F) Effect of Bnl pathway mutations on spry expression in the
ine-rich proteins that appear to block signaling bydeveloping DB, visualized by immunostaining of spry9143 enhancer
trap marker. (B), (C), and (E) were also stained with lumenal antisera binding the inducer or competing with it for receptor
to show branches that don't express spry. activation.
(B) Wild-type, stage-12 embryo showing the two normal spry- Spry appears to be the prototype of a new family
expressing cells DB1 and 2. Lu, lumen of the DB.
of antagonists. Like the others, Spry is a cysteine-rich(C) btlLG19 mutant. The DB does not grow out and tracheal cells fail
signaling protein, although there is little sequence simi-to express spry. spry expression in oenocytes of same embryo is
larity to otherantagonist families beyond the preponder-unaffected (inset).
(D) UAS-bnl/1; hsGal4/1 embryo in which Bnl was expressed ubiq- ance of cysteines.The 124-residue cysteine-richdomain
uitously. spry is induced in all tracheal cells. of Spry is highly conserved, however, in three human
(E) pntD88, stage-15 embryo. Tracheal cells fail to express spry. and several recently identified mouse homologs. The
(F) UAS-pntP1.3/1; hsGal4/1 embryo in which the pnt P1 protein
strong conservation of the cysteine-rich domain in allwas expressed ubiquitously. spry is induced in all tracheal cells,
Spry family members suggests that it is the functionalalthough expression is lower outside the normal expression domain,
core of the proteins, and indeed all of the spry EMSpresumably because of the repressor Yan.
(G) Bnl-Spry regulatory circuit. Bnl protein activates the Btl receptor mutations remove or truncate this domain. Because spry
and induces degradation of Yan and activation of Pnt and Spry gene is expressed in conjunction with FGF pathways in sev-
expression as well as DSRF and other terminal branching genes eral developing tissues, as are vertebrate Spry homo-
(not indicated) at the ends of growing primary branches. High levels
logs (G. Minowada et al., unpublished data), and be-of Spry protein in the tip cells act nonautonomously to block Bnl
cause Spry appears to function as a signaling inhibitorsignaling to the more distant stalk cells. This limits the range of Bnl
in other tissues where it has been studied (S. K. et al.,signaling, so only the cell(s) closest to the Bnl signaling center go
on to form secondary and terminal branches. The others remain as unpublished data; Hacohen, 1997), the general function
unbranched stalk cells. of these proteins may be as antagonists of FGF signaling
or possibly other RTK pathways.
effects mediated by the Notch pathway (Artavanis-Tsa-
konas et al., 1995), so Spry could conceivably activate
Notch or another receptor in the prestalk cells and block Patterning of Branch Budding
This work, together with recent studies of Bnl and Btlsignaling downstream of the Btl receptor. If so, the block
must occur at or upstream of MAPK and Yan, because (Lee et al., 1996; Sutherland et al., 1996), provides a
molecular basis for patterning of secondary bud siteswe showed that Spry counteracts the MAP kinase±
dependent degradation of Yan. in tracheal development. The results support a model
in which the apical bias in secondary branching resultsAny model of Spry action must account for the para-
doxical observation that Bnl signaling is highest in the from expression of two opposing signals, Bnl and Spry,
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balanced stocks using the 35UZ-2 TM3 lacZ balancer chromosome.in close but separate signaling centers near each pro-
Excision alleles were scored for tracheal defects after staining forspective bud site. Bnl, the inducer, is expressed in dis-
mAb2A12 antigen and b-galactosidase and were also tested forcrete patches that appear to be prepatterned in the
lethality. Among the three spry alleles, only spryD55 retained the lacZ
epidermal and mesodermal tissues surrounding the tra- expression pattern. Eight other excision alleles displayed tracheal
cheal epithelium. This specifies the general regions in phenotypes (occasional LT breaks), but these were unrelated to
the spry phenotype and were not characterized further. The EMS-the tracheal epithelium where new branches can bud.
induced alleles were recovered in a screen for dominant suppres-The inhibitor Spry is induced nearby in the tracheal epi-
sors of the rough-eye phenotype caused by ectopic expression ofthelium. This establishes an inhibitory signaling center
seven-up in photoreceptors R2 and R5 (Kramer et al., 1995). Theythat limits the bud sites to the zone of cells closest to
are referred to as spry211, spry226, spry254, spryG5, and spryF7. Chromo-
the Bnl signaling center, which receive the highest levels somal deficiencies Df(3L)1226 and Df(3L)Hr298 (Wohlwill and Bon-
of inducing signal. Cells located farther away are fully ner, 1991) uncover the 63D1,2 region. Southern blot analysis con-
firmed that Df(3L)1226 removes all spry exons.capable of responding to the inducer, and indeed all
The following null or strong loss of function alleles were used:tracheal cells sprout secondary and terminal branches
bnlP1 (Sutherland et al., 1996), btlLG18, btlLG19 (KlaÈmbt et al., 1992),when Bnl is ubiquitously expressed. But in the natural
pntD88 (Scholz et al., 1993), and yan5433 (from I. Rebay and G. Rubin).situation, cells away from the tips of primary branches
The P[lacZ] enhancer trap markers used were pnt7825 (Samakovlis
remain unbranched because the signaling range of the et al., 1996), btl6-81a (Bier et al., 1989), yanP (Lai and Rubin, 1992),
inducer is limited by Spry. Terminal-1 (pruned/DSRF), -2, -3, and -4 (Guillemin et al., 1996;
Samakovlis et al., 1996), 1-eve-1 (Perrimon et al., 1991), and spry9143.Not all secondary branches sprout strictly from apical
spry9143 has the strongest lacZ expression, although the other sprypositions, however, and the exceptional cases are in-
enhancer trap lines show the same pattern. The string-lacZ trans-structive. In the visceral branch, Bnl is expressed in a
gene was P[w1]STGb6C from B. Edgar.broad domain along the distal half of the growing pri-
mary branch, and secondary budding is induced from
Immunostaining and In Situ Hybridization of Embryosthe tip half way down the stalk of the branch (Sutherland
Embryos were fixed and stained with antibodies as described (Sa-
et al., 1996). The Spry feedback circuit is operative, but makovlis et al., 1996). Other antibodies used were mAb2-161 (used
here it prevents secondary budding at the base of the at 1:1000 dilution) to DSRF (from M. Gilman), mAb A2 8B12 to Yan
branch. Bnl can also direct exclusively lateral budding (1:5, from I. Rebay and G. Rubin), andmAbC17.9C6 to Notch (1:3000,
from S. Artavanis-Tsakonas). Biotin-, Cy5-, Cy3-, and FITC-conju-when expressed at the side of a primary branch, and
gated secondary antibodies (Jackson) were used at 1:300. BrdUhere, too, Spry restricts the budding zone. The key point
and TUNEL staining (Samakovlis et al., 1996) were done on spryD5is there are no intrinsic properties of the end of a growing
embryos (stages 10±16).tracheal branch that distinguish it as the budding site, To prepare Spry antisera, full-length (nucleotides 1323-3098),
like the apical meristem of plants. The only significant N-terminal (1509-2708), and C-terminal (2772-3098) coding frag-
feature of a secondary bud site appears tobe its proxim- ments from the spry 12.2 cDNA were amplified by polymerase chain
reaction and inserted 39 of the glutathione S-transferase (GST) cod-ity to an FGF signaling center and the ensuing induction
ing sequences in pGEX-4T-2 (Pharmacia). The GST-Spry fusionof the Spry inhibitor.
proteins were purified by glutathione affinity chromatography andA number of branching inhibitors have been discov-
injected into rabbits and mice (Josman Labs). Antisera were affinity-
ered recently in mammalian systems, and several have purified using the full-length GST-Spry fusion coupled to agarose
received considerable attention because they can strik- beads and then preabsorbed overnight at 48C against fixed embryos
ingly suppress tumor growth by blocking angiogenesis (0±2 hr old) and used at approximately 1:1000 dilution.
In situ hybridization of whole-mount embryos (Tautz and Pfeifle,(Hanahan and Folkman, 1996). The natural functions
1989) was done with random-primed, digoxigenin-labeled spry cDNAof mammalian branching inhibitors, however, are still
12.2 as probe. Similar results were obtained with the 8 kb HindIII/poorly understood. Like the Drosophila tracheal system,
BamHI spry genomic fragment.
complex branched structures, such as the vascular sys-
tem and lungs, are likely to be patterned by a balance
Genetic Mosaic Analysisbetween localized inducers and inhibitors of branching
The spryD5 mutation was recombined onto the left arm of an FRT-
(Wolpert, 1983). Given the extensive evolutionary con- containing third chromosome from strain 80-w1 (Xu and Rubin,
servation of signaling pathways and patterning mecha- 1993), as was the tracheal lacZ enhancer trap marker 1-eve-1. Em-
nisms and the prominent role of FGFs as branching bryos of genotype hsFLP; spryD5, FRT / 1-eve-1, FRT were reared
at 258C, heat-shocked twice at 378C for 20 min at 5 and 6 hr afterinducers in mammals, perhaps some of the known inhib-
egg lay to express FLP recombinase, and returned to 258C for 10 hr.itors or the Spry homologs described here will be found
Embryos were stained with mAb2A12 and an anti-b-galactosidaseto pattern mammalian organs in a similar manner as
antiserum; spryD5/spryD5 clones were identified as tracheal cells that
Spry. did not express b-galactosidase. Clones were found in approxi-
mately 12% of embryos of the correct genotype. DB and GB clones
were examined under DIC optics for extra cytoplasmic extensionsExperimental Procedures
and branches. Only a small number of clones were found in which
GB2-7 cells did not express b-galactosidase, presumably becauseFly Strains and Genetics
these cells are crowded together making it difficult to distinguishThe Pantip-2 enhancer trap lines (s2683, s1814, 1(3)9143) contain
individual cells that do not express the marker.P[lacZ] inserts at 63D1,2 (Samakovlis et al., 1996). s2683 and s1814,
generated in M. Scott's lab, contain a P[lacZ, w1] element (Bier et al.,
1989). Both are homozygous viable with normal tracheal branching. Molecular Biology
Genomic DNA from strain spry2683 was digested with BamHI or EcoRI1(3)9143 (Spradling et al., 1995) is a viable P[lacZ, ry1] insertion, but
the chromosome carries a separate lethal mutation. Excisions of for plasmid rescue in Escherichia coli. An 8 kb HindIII/BamHI frag-
ment (20.6 to 17.4 kb on the genomic map) obtained from BamHI-s2683 were generated by crossing in a third chromosome carrying
D2-3 to supply transposase. One hundred white-eyed (w2) males rescue plasmid pNH6001 was used to screen approximately 105
phage from a Drosophila genomic library in EMBL3 (from J. Tamkun).from independent excision events were isolated and established as
Cell
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The nine phages obtained were restriction mapped with EcoRI and region required for tracheal development. Development 120,
743±753.SalI and tested for cross-hybridization on DNA blots.
The same 8 kb genomic fragment was used to screen approxi- Artavanis-Tsakonas, S., Matsuno, K., and Fortini, M.E. (1995). Notch
mately 106 phage from a 9±12 hr embryonic cDNA library in lgt11 signaling. Science 268, 225±232.
(from K. Zinn). The 11 cDNA clones fell into three size classes: 3.2 Beiman, M., Shilo, B.Z., and Volk, T. (1996). Heartless, a Drosophila
kb (clones 3.1 and 12.2), 2.8 kb (2.4, 3.5, 11.1, 12.4, 13.1, 13.2, 13.3, FGF receptor homolog, is essential for cell migration and establish-
and 13.5), and 1.7 kb (11.3) that correspond to the three transcript ment of several mesodermal lineages. Genes Dev. 10, 2993±3002.
forms. Class assignments were verified by restriction mapping and
Bier, E., Vassein, H., Shepherd, S., Lee, K., McCall, K., Barbel, S.,cross-hybridization of clones on DNA blots. cDNA 12.2 and the
Ackerman, L., Carretto, R., Uemura, T., Grell, E., Jan, L., and Jan, Y.unique portions of cDNAs 11.3 and 13.3 were sequenced on both
(1989). Searching for pattern and mutation in the Drosophila genomestrands and sequences were analyzed with the GCG software pack-
with a P-lacZ vector. Genes Dev. 3, 1273±1287.age. Exons were mapped by hybridization of cDNA fragments to
Brand, A.H., and Perrimon, N. (1993). Targeted gene expression asblots of digested genomic DNA. Intron/exon boundaries were deter-
a means of altering cell fates and generating dominant phenotypes.mined by PCR analysis of genomic DNA using primers from the
Development 118, 401±415.cDNA sequences and by sequencing relevant regions of genomic
Gabay, L., Scholz, H., Golembo, M., Klaes, A., Shilo, B.Z., andDNA.
Klambt, C. (1996). EGF receptor signaling induces pointed P1 tran-Developmental Northern blots were prepared by phenol/chloro-
scription and inactivates Yan protein in the Drosophila embryonicform extraction of total RNA from embryos reared at 258C. poly(A)1
ventral ectoderm. Development 122, 3355±3362.RNA was selected on oligo-dT paramagnetic beads, transferred to
Hybond-N nylon membrane (Amersham), and hybridized with 32P- Glazer, L., and Shilo, B.Z. (1991). The Drosophila FGF-R homolog
labeled probes. is expressed in the embryonic tracheal system and appears to be
Human spry homologs were identified by BLAST searches of the required for directed tracheal cell extension. Genes Dev. 5, 697±705.
NCBI dbEST database. cDNA 142025 (h-Spry1) and cDNA 40262 Golembo, M., Schweitzer, R., Freeman, M., and Shilo, B.Z. (1996).
(h-Spry2) were sequenced on both strands and used along with the Argos transcription is induced by the Drosophila EGF receptor path-
database sequences of AA091040 (h-Spry1), 172013 (h-Spry-1), and way to form an inhibitory feedback loop. Development 122, 223±230.
HSXAP128 (h-Spry3). There is an apparent point mutation in cDNA
Guillemin, K., Groppe, J.,DuÈ cker, K., Treisman, R., Hafen, E., Affolter,
142025.
M., and Krasnow, M.A. (1996). The pruned gene encodes the Dro-
sophila serum response factor and regulates cytoplasmic outgrowth
Molecular Analysis of spry Mutations during terminal branching of the tracheal system. Development 122,
DNA blots of restriction digested genomic DNA from each excision 1353±1362.
allele and a sibling control strain (s5688) were probed with genomic
Hacohen, N. (1997). Branching morphogenesis in the Drosophilafragments flanking the s2683 P insertion site, the full P[lacZ, w1]
tracheal system. PhD thesis, Stanford University, Stanford, Cali-element, and cDNA 12.2. Genomic DNA from each EMS allele was
fornia.isolated from third instar larvae carrying the spry allele in trans to
Hanahan, D., and Folkman, J. (1996). Patterns and emerging mecha-Df(3L)HR119, which uncovers the spry region (Lis et al., 1983). The
nisms of the angiogenic switch during tumorigenesis. Cell 86,spry coding region was amplified by PCR, and two independent
353±364.PCR products of each allele were sequenced.
Klaes, A., Menne, T., Stollewerk, A., Scholz, H., and Klambt, C.
(1994). The Ets transcription factors encoded by the DrosophilaMisexpression of spry and Other Genes In Vivo
gene pointed direct glial cell differentiation in the embryonic CNS.Gal4 driver lines were hsGal4 (Brand and Perrimon, 1993) and C38
Cell 78, 149±160.(Lin and Goodman, 1994) and TrGal4 (from A. Brand), which express
Gal4p in all tracheal cells from stage 13 on. UAS-spry lines were Klambt, C. (1993). The Drosophila gene pointed encodes two ETS-
made by inserting the 2.2 kb EcoRI fragment from cDNA 12.2 con- like proteins which are involved in the development of the midline
taining the complete coding region into the P element vector pUAST glial cells. Development 117, 163±176.
and generating transformant lines. Insertions on the second (UAS- KlaÈmbt, C., Glazer, L., and Shilo, B.Z. (1992). breathless, a Drosophila
spry4.1 #2) and third (UAS-spry1.3 and UAS-spry6.2) chromosomes FGF receptor homolog, is essential for migration of tracheal and
were used with similar results. Other UAS strains were UAS-pntP1.3 specific midline glial cells. Genes Dev. 6, 1668±1678.
(Klaes et al., 1994) and UAS-bnl (Sutherland et al., 1996). For experi- Kramer, S., West, S.R., and Hiromi, Y. (1995). Cell fate control in the
ments with the hsGal4 driver, eggs were collected for approximately Drosophila retina by the orphan receptor seven-up: its role in the
7 hr at 258C, aged for 4 hr at 258C, heat-shocked twice at 378C for decisions mediated by the ras signaling pathway. Development 121,
20 min separated by a 1.5 hr recovery, and then aged 6 hr at 258C. 1361±1372.
For experiments with C38 or TrGal4 drivers, eggs were collected
Lai, Z.-C., and Rubin, G.M. (1992). Negative control of photoreceptor
for 6 hr at 258C and aged at 298C for 9 hr.
development in Drosophila by the product of the yan gene, an ETS
domain protein. Cell 70, 609±620.
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